| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Genetics and Molecular Biology |
Institut de Microbiologie, Centre Hospitalier Universitaire Vaudois (CHUV), Rue de Bugnon, CH-1011 Lausanne, Switzerland1
Author for correspondence: Dominique Sanglard. Tel: +41 21 314 40 83. Fax: +41 21 314 40 60. e-mail: Dominique.Sanglard{at}chuv.hospvd.ch
Azole resistance in Candida albicans can be mediated by several resistance mechanisms. Among these, alterations of the azole target enzyme and the overexpression of multidrug efflux transporter genes are the most frequent. To identify additional putative azole resistance genes in C. albicans, a genomic library from this organism was screened for complementation of fluconazole hypersusceptibility in Saccharomyces cerevisiae YKKB-13 lacking the ABC (ATP-binding cassette) transporter gene PDR5. Among the C. albicans genes obtained, a new gene was isolated and named FLU1 (fluconazole resistance). The deduced amino acid sequence of FLU1 showed similarity to CaMDR1 (formerly BENr), a member of the major facilitator superfamily of multidrug efflux transporters. The expression of FLU1 in YKKB-13 mediated not only resistance to fluconazole but also to cycloheximide among the different drugs tested. The disruption of FLU1 in C. albicans had only a slight effect on fluconazole susceptibility; however, it resulted in hypersusceptibility to mycophenolic acid, thus suggesting that this compound could be a substrate for the protein encoded by FLU1. Disruption of FLU1 in a background of C. albicans mutants with deletions in several multidrug efflux transporter genes, including CDR1, CDR2 and CaMDR1, resulted in enhanced susceptibility to several azole derivatives. FLU1 expression did not vary significantly between several pairs of azole-susceptible and azole-resistant C. albicans clinical isolates. Therefore, FLU1 seems not to be required for the development of azole resistance in clinical isolates.
Keywords: multidrug efflux transporters, azole antifungal agents, Candida albicans
Abbreviations: MF, major facilitator; MFS, major facilitator superfamily; OPC, oropharyngeal candidiasis
The GenBank accession number for the sequence reported in this paper is AF188621.
This article has been cited by other articles:
|
|
 |
|
  L. Angiolella, A. R. Stringaro, F. De Bernardis, B. Posteraro, M. Bonito, L. Toccacieli, A. Torosantucci, M. Colone, M. Sanguinetti, A. Cassone, et al. Increase of Virulence and Its Phenotypic Traits in Drug-Resistant Strains of Candida albicans Antimicrob. Agents Chemother., March 1, 2008; 52(3): 927 - 936. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Shimizu, H. Kinoshita, and T. Nihira Identification and In Vivo Functional Analysis by Gene Disruption of ctnA, an Activator Gene Involved in Citrinin Biosynthesis in Monascus purpureus Appl. Envir. Microbiol., August 15, 2007; 73(16): 5097 - 5103. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Cheng, C. J. Clancy, K. T. Nguyen, W. Clapp, and M. H. Nguyen A Candida albicans Petite Mutant Strain with Uncoupled Oxidative Phosphorylation Overexpresses MDR1 and Has Diminished Susceptibility to Fluconazole and Voriconazole Antimicrob. Agents Chemother., May 1, 2007; 51(5): 1855 - 1858. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Chau, G. Chen, P. M. McNicholas, and P. A. Mann Molecular Basis for Enhanced Activity of Posaconazole against Absidia corymbifera and Rhizopus oryzae Antimicrob. Agents Chemother., November 1, 2006; 50(11): 3917 - 3919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Reimann and H. B. Deising Inhibition of Efflux Transporter-Mediated Fungicide Resistance in Pyrenophora tritici-repentis by a Derivative of 4'-Hydroxyflavone and Enhancement of Fungicide Activity Appl. Envir. Microbiol., June 1, 2005; 71(6): 3269 - 3275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Niimi, K. Niimi, Y. Takano, A. R. Holmes, F. J. Fischer, Y. Uehara, and R. D. Cannon Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance J. Antimicrob. Chemother., December 1, 2004; 54(6): 999 - 1006. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Karababa, A. T. Coste, B. Rognon, J. Bille, and D. Sanglard Comparison of Gene Expression Profiles of Candida albicans Azole-Resistant Clinical Isolates and Laboratory Strains Exposed to Drugs Inducing Multidrug Transporters Antimicrob. Agents Chemother., August 1, 2004; 48(8): 3064 - 3079. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. S. Barker, S. Crisp, N. Wiederhold, R. E. Lewis, B. Bareither, J. Eckstein, R. Barbuch, M. Bard, and P. D. Rogers Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans J. Antimicrob. Chemother., August 1, 2004; 54(2): 376 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Niewerth, D. Kunze, M. Seibold, M. Schaller, H. C. Korting, and B. Hube Ciclopirox Olamine Treatment Affects the Expression Pattern of Candida albicans Genes Encoding Virulence Factors, Iron Metabolism Proteins, and Drug Resistance Factors Antimicrob. Agents Chemother., June 1, 2003; 47(6): 1805 - 1817. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Marchetti, P. Moreillon, J. M. Entenza, J. Vouillamoz, M. P. Glauser, J. Bille, and D. Sanglard Fungicidal Synergism of Fluconazole and Cyclosporine in Candida albicans Is Not Dependent on Multidrug Efflux Transporters Encoded by the CDR1, CDR2, CaMDR1, and FLU1 Genes Antimicrob. Agents Chemother., May 1, 2003; 47(5): 1565 - 1570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Noel, F. Francois, P. Paumard, C. Chastin, D. Brethes, and J. Villard Flucytosine-Fluconazole Cross-Resistance in Purine-Cytosine Permease-Deficient Candida lusitaniae Clinical Isolates: Indirect Evidence of a Fluconazole Uptake Transporter Antimicrob. Agents Chemother., April 1, 2003; 47(4): 1275 - 1284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hayashi, H.-j. Schoonbeek, and M. A. De Waard Bcmfs1, a Novel Major Facilitator Superfamily Transporter from Botrytis cinerea, Provides Tolerance towards the Natural Toxic Compounds Camptothecin and Cercosporin and towards Fungicides Appl. Envir. Microbiol., October 1, 2002; 68(10): 4996 - 5004. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Desmoucelles, B. Pinson, C. Saint-Marc, and B. Daignan-Fornier Screening the Yeast "Disruptome" for Mutants Affecting Resistance to the Immunosuppressive Drug, Mycophenolic Acid J. Biol. Chem., July 19, 2002; 277(30): 27036 - 27044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Jia, B. Arthington-Skaggs, W. Lee, C. A. Pierson, N. D. Lees, J. Eckstein, R. Barbuch, and M. Bard Candida albicans Sterol C-14 Reductase, Encoded by the ERG24 Gene, as a Potential Antifungal Target Site Antimicrob. Agents Chemother., April 1, 2002; 46(4): 947 - 957. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Marchetti, P. A. Majcherczyk, M. P. Glauser, J. Bille, P. Moreillon, and D. Sanglard Sensitive Bioassay for Determination of Fluconazole Concentrations in Plasma Using a Candida albicans Mutant Hypersusceptible to Azoles Antimicrob. Agents Chemother., March 1, 2001; 45(3): 696 - 700. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
